Lysvulpen vakcina A.U.V.
Lysvulpen vakcina A.U.V.
Authorised
- Rabies virus, strain SAD B19, Live
- Rabies virus, strain SAD Bern, Live
Product identification
Medicine name:
Lysvulpen vakcina A.U.V.
Active substance:
- Rabies virus, strain SAD B19, Live
- Rabies virus, strain SAD Bern, Live
Target species:
-
Fox
-
Raccoon dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD B19, Live6.25/log10 50% tissue culture infectious dose1.00unit(s)/dose
-
Rabies virus, strain SAD Bern, Live6.25/log10 50% tissue culture infectious dose1.00unit(s)/dose
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Package description:
- Available only in Hungarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alphavet Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
